首页> 外文期刊>Hepatitis Monthly >INTERFERON-λ GENETIC VARIATIONS AND HEPATITIS C: YET TO BE DISCOVERED
【24h】

INTERFERON-λ GENETIC VARIATIONS AND HEPATITIS C: YET TO BE DISCOVERED

机译:干扰素-λ基因变异和丙型肝炎:尚待发现

获取原文
       

摘要

Dear Editor, The association of genetic factors with treatment induced hepatitis C clearance in Pakistani patients was recently demonstrated by Tipu et al. They evaluated the impact of different genetic variants in interferon- l (IFNL) genomic region on treatment induced hepatitis C clearance. The study was remarkable regarding the investigation of several numbers of single nucleotide polymorphisms (SNPs) in IFNL region. We would like to express our comments regarding the study. We observed that the patients in the study were treated with interferon (IFN) alpha 2b and ribavirin (RBV).
机译:亲爱的编辑,Tipu等人最近证实了遗传因素与巴基斯坦患者丙型肝炎的治疗引起的关联。他们评估了干扰素(IFNL)基因组区域中不同遗传变异对治疗引起的丙型肝炎清除率的影响。关于对IFNL区域中若干个单核苷酸多态性(SNP)的研究,这项研究意义非凡。我们想对这项研究发表意见。我们观察到研究中的患者接受了干扰素(IFN)α2b和利巴韦林(RBV)的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号